Literature DB >> 16336835

Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.

Lian Ma1, Xue-yong Feng, Bing-lin Cui, Frieda Law, Xue-wu Jiang, Li-Ye Yang, Qing-dong Xie, Tian-hua Huang.   

Abstract

BACKGROUND: The two most basic properties of mesenchymal stem cells (MSCs) are the capacities to self-renew indefinitely and differentiate into multiple cells and tissue types. The cells from human umbilical cord Wharton's Jelly have properties of MSCs and represent a rich source of primitive cells. This study was conducted to explore the possibility of inducing human umbilical cord Wharton's Jelly-derived MSCs to differentiate into nerve-like cells.
METHODS: MSCs were cultured from the Wharton's Jelly taken from human umbilical cord of babies delivered after full-term normal labor. Salvia miltiorrhiza and beta-mercaptoethanol were used to induce the human umbilical cord-derived MSCs to differentiate. The expression of neural protein markers was shown by immunocytochemistry. The induction process was monitored by phase contrast microscopy, electron microscopy (EM), and laser scanning confocal microscopy (LSCM). The pleiotrophin and nestin genes were measured by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: MSCs in the Wharton's Jelly were easily attainable and could be maintained and expanded in culture. They were positive for markers of MSCs, but negative for markers of hematopoietic cells and graft-versus-host disease (GVHD)-related cells. Treatment with Salvia miltiorrhiza caused Wharton's Jelly cells to undergo profound morphological changes. The induced MSCs developed rounded cell bodies with multiple neurite-like extensions. Eventually they developed processes that formed networks reminiscent of primary cultures of neurons. Salvia miltiorrhiza and beta-mercaptoethanol also induced MSCs to express nestin, beta-tubulinIII, neurofilament (NF) and glial fibrillary acidic protein (GFAP). It was confirmed by RT-PCR that MSCs could express pleiotrophin both before and after induction by Salvia miltiorrhiza. The expression was markedly enhanced after induction and the nestin gene was also expressed.
CONCLUSIONS: MSCs could be isolated from human umbilical cord Wharton's Jelly. They were capable of differentiating into nerve-like cells using Salvia miltiorrhiza or beta-mercaptoethanol. The induced MSCs not only underwent morphologic changes, but also expressed the neuron-related genes and neuronal cell markers. They may represent an alternative source of stem cells for central nervous system cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336835

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  52 in total

Review 1.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 2.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

3.  Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.

Authors:  Tiki Bakhshi; Ryan C Zabriskie; Shamanique Bodie; Shannon Kidd; Susan Ramin; Laura A Paganessi; Stephanie A Gregory; Henry C Fung; Kent W Christopherson
Journal:  Transfusion       Date:  2008-09-16       Impact factor: 3.157

4.  Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications.

Authors:  Anastasia Petsa; Sofia Gargani; Antigonos Felesakis; Nikolaos Grigoriadis; Ioannis Grigoriadis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

5.  Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Authors:  Dongjie Li; Jiake Chai; Chuanan Shen; Yanfu Han; Tianjun Sun
Journal:  Cytotechnology       Date:  2014-06-21       Impact factor: 2.058

6.  Induction of human umbilical Wharton's jelly-derived mesenchymal stem cells toward motor neuron-like cells.

Authors:  Zohreh Bagher; Somayeh Ebrahimi-Barough; Mahmoud Azami; Hamid Mirzadeh; Mansooreh Soleimani; Jafar Ai; Mohammad Reza Nourani; Mohammad Taghi Joghataei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-07       Impact factor: 2.416

Review 7.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 8.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

9.  Stem cells for reprogramming: could hUMSCs be a better choice?

Authors:  Paulina Duya; Yuhong Bian; Xiaoqian Chu; Yanjun Zhang
Journal:  Cytotechnology       Date:  2012-09-12       Impact factor: 2.058

10.  Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential.

Authors:  Marianne Messerli; Anna Wagner; Ruth Sager; Martin Mueller; Marc Baumann; Daniel V Surbek; Andreina Schoeberlein
Journal:  Reprod Sci       Date:  2013-05-13       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.